Potentially Inappropriate Medication and Associated Factors Among Older Patients with Chronic Coronary Syndrome at Hospital Discharge in Beijing, China

References

• Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222.33069326
   PubMed Web of Science ®Google Scholar
• Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol. 2016;594(8):2061–2073. doi:10.1113/JP27053826391109
   PubMed Web of Science ®Google Scholar
• Knuuti J, Wijns W, Saraste A, et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407–477.31504439
   PubMed Web of Science ®Google Scholar
• Koren G, Nordon G, Radinsky K, Shalev V. Clinical pharmacology of old age. Expert Rev Clin Pharmacol. 2019;12(8):749–755. doi:10.1080/17512433.2019.163218831232610
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society. 2019 updated AGS Beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.1576730693946
   PubMed Web of Science ®Google Scholar
• Masumoto S, Sato M, Maeno T, Ichinohe Y, Maeno T. Potentially inappropriate medications with polypharmacy increase the risk of falls in older Japanese patients: 1-Year Prospective Cohort Study. Geriatr Gerontol Int. 2018;18(7):1064–1070. doi:10.1111/ggi.1330729582533
   PubMed Web of Science ®Google Scholar
• Bonfiglio V, Umegaki H, Kuzuya M. Potentially inappropriate medications and polypharmacy: a study of older people with mild cognitive impairment and mild dementia. J Alzheimers Dis. 2019;71(3):889–897. doi:10.3233/JAD-19028431450496
   PubMed Web of Science ®Google Scholar
• Wang P, Wang Q, Li F, Bian M, Yang K. Relationship between potentially inappropriate medications and the risk of hospital readmission and death in hospitalized older patients. Clin Interv Aging. 2019;14:1871–1878. doi:10.2147/CIA.S21884931806945
   PubMed Web of Science ®Google Scholar
• Hyttinen V, Jyrkkä J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950–964. doi:10.1097/MLR.000000000000058727367864
   PubMed Web of Science ®Google Scholar
• Harrison SL, Kouladjian OL, Milte R, et al. Costs of potentially inappropriate medication use in residential aged care facilities. BMC Geriatr. 2018;18(1):9. doi:10.1186/s12877-018-0704-829325531
   PubMed Web of Science ®Google Scholar
• Sheikh-Taha M, Dimassi H. Potentially inappropriate home medications among older patients with cardiovascular disease admitted to a cardiology service in USA. BMC Cardiovasc Disord. 2017;17(1):189. doi:10.1186/s12872-017-0623-128716041
   PubMed Web of Science ®Google Scholar
• Ivanova I, Elseviers M, Wettermark B, Schmidt MK, Vander SR, Christiaens T. Electronic assessment of cardiovascular potentially inappropriate medications in an administrative population database. Basic Clin Pharmacol Toxicol. 2019;124(1):62–73. doi:10.1111/bcpt.1309529998587
   PubMed Web of Science ®Google Scholar
• Abegaz TM, Birru EM, Mekonnen GB. Potentially inappropriate prescribing in Ethiopian geriatric patients hospitalized with cardiovascular disorders using START/STOPP criteria. PLoS One. 2018;13(5):e0195949. doi:10.1371/journal.pone.019594929723249
   PubMed Web of Science ®Google Scholar
• Lai YR, Yang YS, Tsai ML, et al. Impact of potentially inappropriate medication and continuity of care in a sample of Taiwan elderly patients with diabetes mellitus who have also experienced heart failure. Geriatr Gerontol Int. 2016;16(10):1117–1126. doi:10.1111/ggi.1260626492893
   PubMed Web of Science ®Google Scholar
• Madhavan MV, Gersh BJ, Alexander KP, Granger CB, Stone GW. Coronary artery disease in patients ≥80 years of age. J Am Coll Cardiol. 2018;71(18):2015–2040. doi:10.1016/j.jacc.2017.12.06829724356
   PubMed Web of Science ®Google Scholar
• Guillot J, Maumus-Robert S, Marceron A, Noize P, Pariente A, Bezin J. The burden of potentially inappropriate medications in chronic polypharmacy. J Clin Med. 2020;9(11):3728. doi:10.3390/jcm9113728
   PubMed Web of Science ®Google Scholar
• Maclagan LC, Maxwell CJ, Gandhi S, et al. Frailty and potentially inappropriate medication use at nursing home transition. J Am Geriatr Soc. 2017;65(10):2205–2212. doi:10.1111/jgs.1501628752589
   PubMed Web of Science ®Google Scholar
• Caraballo C, Desai NR, Mulder H, et al. Clinical implications of the New York Heart Association classification. J Am Heart Assoc. 2019;8(23):e014240. doi:10.1161/JAHA.119.01424031771438
   PubMed Web of Science ®Google Scholar
• Carbone RG, Paredi P, Monselise A, Bottino G, Puppo F. New York Heart Association class associated with imaging is a prognostic mortality risk predictor in interstitial lung diseases. Eur Rev Med Pharmacol Sci. 2020;24(17):9012–9021. doi:10.26355/eurrev_202009_2284432964991
   PubMed Web of Science ®Google Scholar
• Apinarová M, Apinar J, Pařenica J, et al. Prescription and dosage of RAAS inhibitors in patients with chronic heart failure in the FAR NHL registry. Vnitr Lek. 2019;65(1):13–14. doi:10.36290/vnl.2019.00430823832
   PubMedGoogle Scholar
• Schjødt I, Johnsen SP, Strömberg A, Valentin JB, Løgstrup BB. Inequalities in heart failure care in a tax-financed universal healthcare system: a Nationwide Population-Based Cohort Study. ESC Heart Fail. 2020;7(5):3095–3108. doi:10.1002/ehf2.1293832767628
   PubMed Web of Science ®Google Scholar
• Maliwa MA, van der Heijden GJ, Bots ML, et al. Quality of life and NYHA class 30 years after mechanical aortic valve replacement. Cardiovasc Surg. 2003;11(5):381–387. doi:10.1016/S0967-2109(03)00030-912958549
   PubMedGoogle Scholar
• Ie K, Felton M, Springer S, Wilson SA, Albert SM. Physician factors associated with polypharmacy and potentially inappropriate medication use. J Am Board Fam Med. 2017;30(4):528–536. doi:10.3122/jabfm.2017.04.17012128720634
   PubMed Web of Science ®Google Scholar
• Vrettos I, Voukelatou P, Katsoras A, Theotoka D, Kalliakmanis A. Diseases linked to polypharmacy in elderly patients. Curr Gerontol Geriatr Res. 2017;2017:4276047. doi:10.1155/2017/427604729434639
   PubMedGoogle Scholar
• Denfeld QE, Winters-Stone K, Mudd JO, Gelow JM, Kurdi S, Lee CS. The prevalence of frailty in heart failure: a systematic review and meta-analysis. Int J Cardiol. 2017;236:283–289. doi:10.1016/j.ijcard.2017.01.15328215466
   PubMed Web of Science ®Google Scholar
• Ma L, Tang Z, Zhang L, Sun F, Li Y, Chan P. Prevalence of frailty and associated factors in the community-dwelling population of China. J Am Geriatr Soc. 2018;66(3):559–564. doi:10.1111/jgs.1521429168883
   PubMed Web of Science ®Google Scholar
• Beard JR, Officer A, de Carvalho IA, et al. The world report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145–2154. doi:10.1016/S0140-6736(15)00516-426520231
   PubMed Web of Science ®Google Scholar
• Alfandre DJ. “I’m going home”: discharges against medical advice. Mayo Clin Proc. 2009;84(3):255–260.19252113
   PubMed Web of Science ®Google Scholar
• Morin L, Laroche ML, Texier G, Johnell K. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862.e1–9. doi:10.1016/j.jamda.2016.06.011
   Web of Science ®Google Scholar
• Abolhassani N, Marques-Vidal P. Polypharmacy, defined as taking five or more drugs, is inadequate in the cardiovascular setting. J Clin Epidemiol. 2018;101:1–4. doi:10.1016/j.jclinepi.2018.05.00229777797
   PubMed Web of Science ®Google Scholar
• Kheshti R, Aalipour M, Namazi S. A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness. J Res Pharm Pract. 2016;5(4):257–263. doi:10.4103/2279-042X.19246127843962
   PubMed Web of Science ®Google Scholar
• Lin JX, Huang YQ, Xie JW, et al. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer. BMC Surg. 2019;19(1):53. doi:10.1186/s12893-019-0513-931133008
   PubMed Web of Science ®Google Scholar
• Chan TC, Luk JK, Chu LW, Chan FH. Validation study of charlson comorbidity index in predicting mortality in Chinese older adults. Geriatr Gerontol Int. 2014;14(2):452–457. doi:10.1111/ggi.1212924020396
   PubMed Web of Science ®Google Scholar
• Morley JE, Malmstrom TK, Miller DK. A simple frailty questionnaire (FRAIL) predicts outcomes in middle aged African Americans. J Nutr Health Aging. 2012;16(7):601–608. doi:10.1007/s12603-012-0084-222836700
   PubMed Web of Science ®Google Scholar
• Kimura T, Ogura F, Kukita Y, et al. Efficacy of pharmacists’ assessment and intervention based on screening tool for older persons’ appropriate prescriptions for Japanese compared with screening tool of older persons’ potentially inappropriate prescriptions criteria version 2 in older patients with cardiovascular disease. Geriatr Gerontol Int. 2019;19(11):1101–1107. doi:10.1111/ggi.1377331746526
   PubMed Web of Science ®Google Scholar
• Gallagher P, Lang PO, Cherubini A, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011;67(11):1175–1188. doi:10.1007/s00228-011-1061-021584788
   PubMed Web of Science ®Google Scholar
• Muhlack DC, Hoppe LK, Stock C, Haefeli WE, Brenner H, Schöttker B. The associations of geriatric syndromes and other patient characteristics with the current and future use of potentially inappropriate medications in a large Cohort Study. Eur J Clin Pharmacol. 2018;74(12):1633–1644. doi:10.1007/s00228-018-2534-130159676
   PubMed Web of Science ®Google Scholar
• Zhang L, Desai NR, Li J, et al. National quality assessment of early clopidogrel therapy in Chinese patients with acute myocardial infarction (AMI) in 2006 and 2011: insights from the China patient-centered evaluative assessment of cardiac events (PEACE)-retrospective AMI study. J Am Heart Assoc. 2015;4(7):e001906. doi:10.1161/JAHA.115.00190626163041
   PubMed Web of Science ®Google Scholar
• Huang Y, Zhang L, Huang X, Liu K, Yu Y, Xiao J. Potentially inappropriate medications in Chinese community-dwelling older adults. Int J Clin Pharm. 2020;42(2):598–603. doi:10.1007/s11096-020-00980-y32026350
   PubMed Web of Science ®Google Scholar
• He D, Zhu H, Zhou H, Dong N, Zhang H. Potentially inappropriate medications in Chinese older adults: a comparison of two updated Beers criteria. Int J Clin Pharm. 2021;43(1):229–235. doi:10.1007/s11096-020-01139-532920684
   PubMed Web of Science ®Google Scholar
• Zahwe M, Skouri H, Rachidi S, et al. Potentially inappropriate medications in elderly patients with heart failure: Beers Criteria-Based Study. Int J Pharm Pract. 2020;28(6):652–659. doi:10.1111/ijpp.1265132677747
   PubMed Web of Science ®Google Scholar
• Sinha AD, Agarwal R. Thiazide diuretics in chronic kidney disease. Curr Hypertens Rep. 2015;17(3):13. doi:10.1007/s11906-014-0525-x25749608
   PubMed Web of Science ®Google Scholar
• Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Hypertension. 2018;71(6):e13–e115. doi:10.1161/HYP.000000000000006529133356
   PubMed Web of Science ®Google Scholar
• Akande-Sholabi W, Adebusoye LA, Olowookere OO. Potentially inappropriate medication use among older patients attending a geriatric centre in south-west Nigeria. Pharm Pract (Granada). 2018;16(3):1235. doi:10.18549/PharmPract.2018.03.123530416626
   PubMed Web of Science ®Google Scholar
• Patel MJ, Ahmer S, Khan F, Qureshi AW, Shehzad MF, Muzaffar S. Benzodiazepine use in medical out-patient clinics: a study from a developing country. J Pak Med Assoc. 2013;63(6):717–720.23901671
   PubMed Web of Science ®Google Scholar
• Mesrine S, Gusto G, Clavel-Chapelon F, Boutron-Ruault MC, Fournier A. Use of benzodiazepines and cardiovascular mortality in a cohort of women aged over 50 years. Eur J Clin Pharmacol. 2018;74(11):1475–1484. doi:10.1007/s00228-018-2515-429971451
   PubMed Web of Science ®Google Scholar
• Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. doi:10.1111/jsr.1259428875581
   PubMed Web of Science ®Google Scholar
• Sharma R, Chhabra M, Vidyasagar K, Rashid M, Fialova D, Bhagavathula AS. Potentially inappropriate medication use in older hospitalized patients with type 2 diabetes: a Cross-Sectional Study. Pharmacy (Basel). 2020;8(4):219. doi:10.3390/pharmacy8040219
   Google Scholar
• Filion KB, Douros A, Azoulay L, Yin H, Yu OH, Suissa S. Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: a Population-Based Cohort Study. Br J Clin Pharmacol. 2019;85(10):2378–2389. doi:10.1111/bcp.1405631276600
   PubMed Web of Science ®Google Scholar
• Douros A, Yin H, Yu O, Filion KB, Azoulay L, Suissa S. Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events. Diabetes Care. 2017;40(11):1506–1513. doi:10.2337/dc17-059528864502
   PubMed Web of Science ®Google Scholar
• Abe H, Shikuma J, Suwanai H, et al. Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents. Geriatr Gerontol Int. 2019;19(10):1030–1035. doi:10.1111/ggi.1376531486247
   PubMed Web of Science ®Google Scholar
• Yao X, Abraham NS, Alexander GC, et al. Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc. 2016;5(2):e003074. doi:10.1161/JAHA.115.00307426908412
   PubMed Web of Science ®Google Scholar
• Wang X, Fang L, Liu B, Zheng Y, Zeng J. Real-world comparisons of reduced-dose non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation: a systematic review and meta-analysis. Heart Fail Rev. 2020;25(6):973–983. doi:10.1007/s10741-019-09887-x31713086
   PubMed Web of Science ®Google Scholar
• Bisson A, Angoulvant D, Philippart R, Clementy N, Babuty D, Fauchier L. Non-vitamin K oral anticoagulants for stroke prevention in special populations with atrial fibrillation. Adv Ther. 2017;34(6):1283–1290. doi:10.1007/s12325-017-0550-728493056
   PubMed Web of Science ®Google Scholar
• Mafi JN, May FP, Kahn KL, et al. Low-value proton pump inhibitor prescriptions among older adults at a large academic health system. J Am Geriatr Soc. 2019;67(12):2600–2604. doi:10.1111/jgs.1611731486549
   PubMed Web of Science ®Google Scholar
• Pang J, Wu Q, Zhang Z, et al. Efficacy and safety of clopidogrel only vs. clopidogrel added proton pump inhibitors in the treatment of patients with coronary heart disease after percutaneous coronary intervention: a systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2019;23::100317. doi:10.1016/j.ijcha.2018.12.01631321282
   PubMed Web of Science ®Google Scholar
• Farcas A, Leucuta D, Bucsa C, Mogosan C, Dumitrascu D. Combined use of renin-angiotensin-aldosterone system-acting agents: a Cross-Sectional Study. Int J Clin Pharm. 2016;38(6):1390–1397. doi:10.1007/s11096-016-0378-227677980
   PubMed Web of Science ®Google Scholar
• Chen Q, Zhu S, Liao J, He W. Study of acute kidney injury on 309 hypertensive inpatients with ACEI/ARB - diuretic treatment. J Natl Med Assoc. 2018;110(3):287–296. doi:10.1016/j.jnma.2017.06.00829778133
   PubMed Web of Science ®Google Scholar
• Vidán MT, Blaya-Novakova V, Sánchez E, Ortiz J, Serra-Rexach JA, Bueno H. Prevalence and prognostic impact of frailty and its components in non-dependent elderly patients with heart failure. Eur J Heart Fail. 2016;18(7):869–875. doi:10.1002/ejhf.51827072307
   PubMed Web of Science ®Google Scholar
• Mori AL, Carvalho RC, Aguiar PM, et al. Potentially inappropriate prescribing and associated factors in elderly patients at hospital discharge in Brazil: a Cross-Sectional Study. Int J Clin Pharm. 2017;39(2):386–393. doi:10.1007/s11096-017-0433-728188508
   PubMed Web of Science ®Google Scholar
• Leger DY, Moreau S, Signol N, et al. Polypharmacy, potentially inappropriate medications and drug-drug interactions in geriatric patients with hematologic malignancy: observational Single-Center Study of 122 patients. J Geriatr Oncol. 2018;9(1):60–67. doi:10.1016/j.jgo.2017.07.01528851511
   PubMed Web of Science ®Google Scholar
• Hudhra K, García-Caballos M, Casado-Fernandez E, Jucja B, Shabani D, Bueno-Cavanillas A. Polypharmacy and potentially inappropriate prescriptions identified by Beers and STOPP criteria in co-morbid older patients at hospital discharge. J Eval Clin Pract. 2016;22(2):189–193. doi:10.1111/jep.1245226399173
   PubMed Web of Science ®Google Scholar
• Sargent L, Flattery M, Shah K, et al. Influence of physiological and psychological factors on cognitive dysfunction in heart failure patients. Appl Nurs Res. 2020;56:151375. doi:10.1016/j.apnr.2020.15137533280793
   PubMed Web of Science ®Google Scholar
• Hashimoto R, Fujii K, Shimoji S, et al. Study of pharmacist intervention in polypharmacy among older patients: non-randomized, controlled trial. Geriatr Gerontol Int. 2020;20(3):229–237. doi:10.1111/ggi.1385031858696
   PubMed Web of Science ®Google Scholar
• Stuhec M, Bratovic N, Mrhar A. Impact of clinical pharmacist’s interventions on pharmacotherapy management in elderly patients on polypharmacy with mental health problems including quality of life: a Prospective Non-Randomized Study. Sci Rep. 2019;9(1):16856. doi:10.1038/s41598-019-53057-w31728029
   PubMed Web of Science ®Google Scholar